Good day and thank you for standing by and welcome to the Heron Therapeutics Q4 2024 conference call. (Operator Instructions) After the speaker's presentation, there will be a question-and-answer ...

I’ll also be profiling Yellow-crowned Night Heron plus taking your calls live on the air. That’s Bird Calls on March 18th at ...

Heron Therapeutics' market cap has risen to ~$360 million, trading at ~$2.38, since my last Hold rating in November 2024.

Adjusted EBITDA Guidance (2025): $0 to $8 million. Heron Therapeutics Inc (NASDAQ:HRTX) achieved profitability for both the fourth quarter and the full year 2024, with a net income of $3.6 million ...

Heron Therapeutics (NASDAQ:HRTX) (market cap: $260 million) reported a profitable fourth quarter for 2024, surpassing earnings expectations with an EPS of $0.02 against a forecast of -$0.03. The ...

Good day, and thank you for standing by, and welcome to the Heron Therapeutics Q4 2024 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation ...

Heron Therapeutics (NASDAQ:HRTX) (market cap: $260 million) reported a profitable fourth quarter for 2024, surpassing earnings expectations with an EPS of $0.02 against a forecast of -$0.03. The ...

Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.02, expectations were $-0.03. Operator: Good day, and thank you for standing by, and welcome to the Heron Therapeutics Q4 ...

Good day and thank you for standing by and welcome to the Heron Therapeutics Q4 2024 conference call. (Operator Instructions) After the speaker's presentation, there will be a question-and-answer ...